Skip to content

ARCHITECT 8D06-31Recalls & reported problems

Abbott GmbH · ARCHITECT Syphilis TP Reagent Kit · Class 1

Adverse event reports
3
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00380740117115), received between Oct 20, 2017 and Dec 12, 2023 — classified as 3 malfunctions.

The most frequently reported specific device problem is “False Negative Result” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 1 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • False Negative Result2
  • False Positive Result1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1
  • No Code Available1
  • No Known Impact Or Consequence To Patient1

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • MalfunctionDec 12, 2023False Negative Result; False Negative Result

    THE CUSTOMER OBSERVED A FALSE NONREACTIVE ARCHITECT SYPHILIS TP RESULT FOR ONE SAMPLE. THE FOLLOWING DATA WAS PROVIDED: SID (B)(6) : ARCHITECT (B)(6) RESULT WAS NONREACTIVE, TITER WAS >256, ARUP RESULT WAS REACTIVE FOR TROUBLESHOOTING PURPOSES ONLY, THE SAMPLE WAS SENT TO ANOTHER LABORATORY AND REPEATED ON ANOTHER ARCHITECT (B)(6) WHICH GENERATED NONREACTIVE RESULTS. NO IMPACT TO PATIENT MANAGEMENT WAS REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 18314130 ↗
  • MalfunctionDec 27, 2019False Positive Result; False Positive Result

    THE CUSTOMER OBSERVED A FALSE REACTIVE ARCHITECT (B)(6) TP RESULT AND WAS INQUIRING IF THE ASSAY HAS ANY CROSS REACTIVITY WITH RED CELL ANTIGENS. THE FOLLOWING DATA WAS PROVIDED FOR THE PATIENT IN QUESTION: INITIAL RESULT = 1.71 S/CO (REACTIVE), MHA TP = REACTIVE, RPR = NONREACTIVE. THE PATIENT IS POSITIVE FOR THE "C" ANTIGEN AND RECENTLY DELIVERED A BABY. THE NEWBORN BABY HAD A SPINAL TAP PROCEDURE TO RETRIEVE CEREBROSPINAL FLUID FOR (B)(6) TESTING: ARCHITECT (B)(6) = REACTIVE, RPR = NONREACTIVE, MHA TP = NONREACTIVE, VDRL = NONREACTIVE. THE SPINAL TAP WAS PERFORMED DUE TO THE FALSE REACTIVE ARCHITECT (B)(6) RESULTS ON THE MOTHER'S SAMPLE.

    Patient problems: No Code Available

    MAUDE report 9527284 ↗
  • MalfunctionOct 20, 2017False Negative Result; False Negative Result

    THE CUSTOMER REPORTED A FALSE NON-REACTIVE ARCHITECT SYPHILIS TP RESULT FOR ONE POSTPARTUM PATIENT THAT WAS PREVIOUSLY TREATED FOR (B)(6). SAMPLE ID (B)(6) GENERATED A NEGATIVE (0.14 S/CO) RESULT ON THE ARCHITECT ASSAY AND POSITIVE ON THE RPR ASSAY. THE CUSTOMER FURTHER INDICATED THE BABY WAS ALSO POSITIVE ON RPR. NO FURTHER PATIENT INFORMATION WAS PROVIDED. NO IMPACT TO PATIENT MANAGEMENT WAS REPORTED.

    Patient problems: No Known Impact Or Consequence To Patient

    MAUDE report 6965649 ↗

Other SINGLE (SPECIFIED) ANALYTE CONTROLS (ASSAYED AND UNASSAYED) devices

All SINGLE (SPECIFIED) ANALYTE CONTROLS (ASSAYED AND UNASSAYED) devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.